
Article 1 
This Decision lays down detailed rules:

((a)) to be applied in order to prevent the spread of highly pathogenic avian influenza virus from birds living in the wild or from outbreaks in poultry or other captive birds, to other captive birds kept in zoos and approved bodies, institutes or centres;
((b)) for the preventive vaccination of other captive birds kept in zoos and approved bodies, institutes or centres.
Article 2 
For the purposes of this Decision, the following definitions shall apply:

((a)) the definitions in Article 2 of Directive 2005/94/EC;
((b)) the definition of zoos in Article 2 of Directive 1999/22/EC;
((c)) the definition of approved bodies, institutes or centres in Article 2(1)(c) of Directive 92/65/EEC.
Article 3 

1. Member States shall take appropriate and practicable measures to reduce the risk of transmission of highly pathogenic avian influenza from birds living in the wild to other captive birds kept in zoos and approved bodies, institutes or centres, taking into account the criteria and risk factors set out in Annex I.
2. Paragraph 1 shall also apply in the event of an outbreak in poultry in the same Member State, a neighbouring Member State or a third country that is liable to endanger the health status of other captive birds kept in zoos and approved bodies, institutes or centres.
3. Depending on the specific epidemiological situation, the measures referred to in paragraph 1 shall, in particular, be directed at preventing direct and indirect contact between birds living in the wild, especially waterfowl, and other captive birds kept in zoos and approved bodies, institutes or centres.
Article 4 
Preventive vaccination plans in respect of other captive birds kept in zoos and approved bodies, institutes or centres, submitted in accordance with Article 56(2) of Directive 2005/94/EC shall comply with the requirements set out in Annex II to this Decision.
Article 5 

1. The preventive vaccination plans submitted in accordance with Article 56(2) of Directive 2005/94/EC and listed in Part I of Annex III to this Decision are hereby approved.
2. The Commission shall publish the approved preventive vaccination plans referred to in paragraph 1.
Article 6 

1. Member States shall, before preventive vaccination is introduced, compile the exact address and location of the zoos and approved bodies, institutes or centres, where vaccination it is to be carried out by allocating approval or registration numbers, as appropriate, and shall keep that information updated.
2. Member States shall submit to the Commission and the other Member States each year, by 30 March at the latest, or upon specific request by the Commission, a report on the implementation of the approved preventive vaccination plans for the preceding year using the reporting model as set out in Annex IV.That report shall be submitted in the framework of the Standing Committee on the Food Chain and Animal Health.
3. Member States shall inform the Commission of the following:
(a) planned amendments to their approved preventive vaccination plans;
(b) the date of cessation of preventive vaccination of other captive birds kept in zoos and approved bodies, institutes or centres.
Article 7 
Decision 2006/474/EC is repealed.
Article 8 
The preventive vaccination plans approved pursuant to Decision 2006/474/EC and listed in Part II of Annex III to this Decision shall be considered as being approved for the purposes of the present Decision.
Article 9 
Member States shall take the necessary measures to comply with this Decision. They shall immediately inform the Commission thereof.
Article 10 
This Decision is addressed to the Member States.
Done at Brussels, 28 August 2007.
For the Commission
Markos KYPRIANOU
Member of the Commission
ANNEX I

1. Location of zoos and approved bodies, institutes or centres along migratory flyways of birds, in particular if proceeding from countries where outbreaks of highly pathogenic avian influenza have occurred, taking into account the serotype detected and the likelihood of wild birds having been affected.

2. Distance of zoos and approved bodies, institutes or centres from wetlands and water areas such as ponds, swamps, lakes or rivers where migratory waterfowl may gather.

3. Location of zoos and approved bodies, institutes or centres in areas of a high density of migratory birds, particularly waterfowl.

ANNEX II
1. Extent of the vaccination to be carried out The vaccination against avian influenza shall only be carried out in birds kept in zoos and approved bodies, institutes or centres. The competent authority shall keep lists of zoos, approved bodies, institutes or centres for a period of at least five years from the date of such vaccination.
2. Bird species to be vaccinated The competent authority shall be notified of a list of birds to be vaccinated together with the individual identification and keep it for at least five years from the date of the vaccination.
3. Duration of vaccination 
(a) All birds to be vaccinated in zoos and approved bodies institutes or centres shall be vaccinated as quickly as possible.

(b) Offspring, newly introduced birds and birds for which an insufficient immune response has been demonstrated must also be vaccinated.

(c) Annual re-vaccination is recommended to maintain bird immunity.

4. Specific requirements for movements of birds 
(a) 
'Birds conform to Decision 2007/598/EC were vaccinated against avian influenza on … (date) with vaccine … (name)'.

(b) 
'Birds conform to Decision 2007/598/EC and vaccinated against avian influenza on … (date) with vaccine … (name)'.

(c) When vaccination of birds kept in zoos, approved bodies, institutes or centres is not longer applied, the conditions for movements laid down in points (a) and (b) shall be maintained for a period of 12 months from the date of the vaccination of the last bird.

5. Special identification and special registration of the vaccinated birds Vaccinated birds must be individually identifiable and the identity records of these birds must be clearly annotated accordingly. An indelible identification of the other captive birds indicating that they have been vaccinated shall be applied at the time of vaccination wherever possible.
6. Execution of the vaccination campaign 
(a) Vaccination shall be carried out under the supervision of a veterinarian and necessary measures must be in place to avoid possible spread of virus.

(b) A written record on the number of vaccinated birds and the number of vaccine doses used shall be communicated to the competent authority after vaccination is carried out and thereafter on a monthly basis, if further birds as referred to in point 3(b) are vaccinated.

(c) Wherever possible blood samples from 10 % of the birds shall be taken prior to and at least 30 days from the date of each vaccination for serological testing for avian influenza. A record of the test results must be kept for at least five years from the date of vaccination.

7. Vaccine to be used The inactivated vaccine to be used shall be suitably formulated and be effective against highly pathogenic avian influenza virus of subtype H5 or H7 or both. It shall be used in accordance with the instructions of the manufacturer and/or the veterinary authorities.
ANNEX III

Part I:
Preventive vaccination plans approved by this Decision and referred to in Article 5(1)
Code Member State Date of submission of plan
BE Belgium 22 March 2007
ES Spain 27 June 2007
FR France 4 January 2007
SE Sweden 7 March 2007
UK United Kingdom 27 June 2007
Part II:
Preventive vaccination plans approved under Decision 2006/474/EC and referred to in Article 8 of the present Decision
Code Member State Date of submission
CZ Czech Republic 21 March 2006
DK Denmark 20 February 2006
DE Germany 31 March 2006
EE Estonia 6 March 2006
IE Ireland 6 March 2006
IT Italy 6 March 2006
LV Latvia 28 February 2006
LT Lithuania 6 March 2006
HU Hungary 1 March 2006
NL The Netherlands 16 November 2005
AT Austria 21 April 2006
PT Portugal 29 November 2005
ANNEX IV
General information
Country Zoo Vaccine Route(specify if different in different species) Weight — Dose regime used(Actual/estimated/average weight of species) Vaccine interval Interval from last vaccination to post-vaccination blood collection
      HI serum antibody titre
English name/local name Latin name Taxonomic Order Individual identification VaccineDose (ml) Pre-vacc Post-1st vacc Post-2nd vacc
       Adverse Individual effects Mortality
Local general Direct(catching/handling) Delayed(specify cause of death)
   Information required from the Laboratory
Virus strain of vaccine Antigens (virus strains) used in HI test Cut-off or end-titre point used as a measure of vaccine efficacy Reference serum used (reference to)Methodology
    